HMOs Not Stoked Over COX-2 Drugs
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
622280
Novartis' pain killer Prexige did not  raise the rate of serious heart problems and led to fewer ulcer  problems compared to normal anti-inflammatory drugs, results of  a study of over 18,000 patients showed.
397851
The controversy over painkillers known as Cox-2 inhibitors like Vioxx, Celebrex and Bextra and major cardiovascular events has prompted a leading heart specialist to speak out.
373977
Two studies released yesterday have turned up new evidence that all of the popular arthritis painkillers known as cox-2 inhibitors may put users at greater risk of heart attacks and strokes.
136421
Millions of Americans have done just that. Thanks to them, a class of pain relievers called COX-2 inhibitors - Pfizer&#39;s Celebrex and Bextra, and Merck&#39;s Vioxx - have become blockbusters.
634059
NEW YORK  - Compared with ibuprofen, the  use of the lumiracoxib by patients with osteoarthritis is  associated with a lower risk of gastric ulcers. The risk is  similar to that seen with celecoxib (Celebrex), another COX-2  inhibitor.
258280
The two popular painkillers Vioxx and  Celebrex, heavily marketed as "super-aspirin," were prescribed  for millions of patients who did not need them or should not  have taken them, researchers said on Friday.
713096
TUESDAY, Aug. 1 (HealthDay News) -- Despite high enrollment in the Medicare prescription drug plan, many who signed up now feel dissatisfied with Medicare because of their experiences with the cumbersome process of choosing coverage plans.
255531
FRIDAY, Dec. 15 (HealthDay News) -- For years, experts have noted that people who take nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief also lower their risk for a variety of cancers.
257427
Since Vioxx was pulled off the market last week, arthritis suffers have had to make difficult choices about alternatives for pain relief.
289198
Novartis' pain killer Prexige did not raise the rate of serious heart problems and led to fewer ulcer problems compared to normal anti-inflammatory drugs, results of a study of over 18,000 patients showed.
466531
New evidence shows all popular arthritis painkillers known as COX-2 inhibitors may put users at greater risk of heart attacks and strokes, the latest addition to the recent crop of safety concerns for the drugs.
189407
U.S. regulators have "serious concerns"  about painkilling drugs in the class known as COX-2 inhibitors  and are due to issue a new ruling on them within days, the  Financial Times reported on its Web site on Sunday.
321009
Scientists in the United States and regulatory agencies in Europe on Wednesdsay questioned whether Celebrex and other pain relievers might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
377945
When news broke Sept. 30 that Merck pulled its blockbuster anti-inflammatory pain reliever Vioxx, a collective sigh was heard across the nation.
514972
Patients who were switched from the prescription pain reliever Vioxx, taken off the market in September, to Celebrex or Aleve want to know what they should do now that the safety of both alternatives is being questioned.
113972
LONDON: Anti-inflammatory drugs that have been used for 30 years to treat serious head injuries are harming rather than helping patients, researchers said.